Coagulation Factor Concentrates Market
1 Study Coverage
1.1 Coagulation Factor Concentrates Product Introduction
1.2 Global Coagulation Factor Concentrates Outlook 2017 VS 2022 VS 2028
1.2.1 Global Coagulation Factor Concentrates Sales in US$ Million for the Year 2017-2028
1.2.2 Global Coagulation Factor Concentrates Sales in Volume for the Year 2017-2028
1.3 United States Coagulation Factor Concentrates Outlook 2017 VS 2022 VS 2028
1.3.1 United States Coagulation Factor Concentrates Sales in US$ Million for the Year 2017-2028
1.3.2 United States Coagulation Factor Concentrates Sales in Volume for the Year 2017-2028
1.4 Coagulation Factor Concentrates Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Coagulation Factor Concentrates in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Coagulation Factor Concentrates Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Coagulation Factor Concentrates Market Dynamics
1.5.1 Coagulation Factor Concentrates Industry Trends
1.5.2 Coagulation Factor Concentrates Market Drivers
1.5.3 Coagulation Factor Concentrates Market Challenges
1.5.4 Coagulation Factor Concentrates Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Coagulation Factor Concentrates Market Segment by Type
2.1.1 Factor VIII
2.1.2 Factor IX
2.1.3 Von Willebrand Factor
2.1.4 Prothrombin Complex Concentrates
2.1.5 Fibrinogen Concentrates
2.1.6 Factor XIII
2.2 Global Coagulation Factor Concentrates Market Size by Type
2.2.1 Global Coagulation Factor Concentrates Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Coagulation Factor Concentrates Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Coagulation Factor Concentrates Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Coagulation Factor Concentrates Market Size by Type
2.3.1 United States Coagulation Factor Concentrates Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Coagulation Factor Concentrates Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Coagulation Factor Concentrates Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Coagulation Factor Concentrates Market Segment by Application
3.1.1 Neurology
3.1.2 Immunology
3.1.3 Hematology
3.1.4 Critical Care
3.1.5 Pulmonology
3.1.6 Hemato-Oncology
3.1.7 Rheumatology
3.1.8 Others
3.2 Global Coagulation Factor Concentrates Market Size by Application
3.2.1 Global Coagulation Factor Concentrates Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Coagulation Factor Concentrates Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Coagulation Factor Concentrates Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Coagulation Factor Concentrates Market Size by Application
3.3.1 United States Coagulation Factor Concentrates Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Coagulation Factor Concentrates Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Coagulation Factor Concentrates Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Coagulation Factor Concentrates Competitor Landscape by Company
4.1 Global Coagulation Factor Concentrates Market Size by Company
4.1.1 Top Global Coagulation Factor Concentrates Manufacturers Ranked by Revenue (2021)
4.1.2 Global Coagulation Factor Concentrates Revenue by Manufacturer (2017-2022)
4.1.3 Global Coagulation Factor Concentrates Sales by Manufacturer (2017-2022)
4.1.4 Global Coagulation Factor Concentrates Price by Manufacturer (2017-2022)
4.2 Global Coagulation Factor Concentrates Concentration Ratio (CR)
4.2.1 Coagulation Factor Concentrates Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Coagulation Factor Concentrates in 2021
4.2.3 Global Coagulation Factor Concentrates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Coagulation Factor Concentrates Manufacturing Base Distribution, Product Type
4.3.1 Global Coagulation Factor Concentrates Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Coagulation Factor Concentrates Product Type
4.3.3 Date of International Manufacturers Enter into Coagulation Factor Concentrates Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Coagulation Factor Concentrates Market Size by Company
4.5.1 Top Coagulation Factor Concentrates Players in United States, Ranked by Revenue (2021)
4.5.2 United States Coagulation Factor Concentrates Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Coagulation Factor Concentrates Sales by Players (2020, 2021 & 2022)
5 Global Coagulation Factor Concentrates Market Size by Region
5.1 Global Coagulation Factor Concentrates Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Coagulation Factor Concentrates Market Size in Volume by Region (2017-2028)
5.2.1 Global Coagulation Factor Concentrates Sales in Volume by Region: 2017-2022
5.2.2 Global Coagulation Factor Concentrates Sales in Volume Forecast by Region (2023-2028)
5.3 Global Coagulation Factor Concentrates Market Size in Value by Region (2017-2028)
5.3.1 Global Coagulation Factor Concentrates Sales in Value by Region: 2017-2022
5.3.2 Global Coagulation Factor Concentrates Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Coagulation Factor Concentrates Market Size YoY Growth 2017-2028
6.1.2 North America Coagulation Factor Concentrates Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Coagulation Factor Concentrates Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Coagulation Factor Concentrates Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Coagulation Factor Concentrates Market Size YoY Growth 2017-2028
6.3.2 Europe Coagulation Factor Concentrates Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Coagulation Factor Concentrates Market Size YoY Growth 2017-2028
6.4.2 Latin America Coagulation Factor Concentrates Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Coagulation Factor Concentrates Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Coagulation Factor Concentrates Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 CSL (Australia)
7.1.1 CSL (Australia) Corporation Information
7.1.2 CSL (Australia) Description and Business Overview
7.1.3 CSL (Australia) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
7.1.4 CSL (Australia) Coagulation Factor Concentrates Products Offered
7.1.5 CSL (Australia) Recent Development
7.2 Grifols (Spain)
7.2.1 Grifols (Spain) Corporation Information
7.2.2 Grifols (Spain) Description and Business Overview
7.2.3 Grifols (Spain) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Grifols (Spain) Coagulation Factor Concentrates Products Offered
7.2.5 Grifols (Spain) Recent Development
7.3 Shire (Ireland)
7.3.1 Shire (Ireland) Corporation Information
7.3.2 Shire (Ireland) Description and Business Overview
7.3.3 Shire (Ireland) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Shire (Ireland) Coagulation Factor Concentrates Products Offered
7.3.5 Shire (Ireland) Recent Development
7.4 Octapharma (Switzerland)
7.4.1 Octapharma (Switzerland) Corporation Information
7.4.2 Octapharma (Switzerland) Description and Business Overview
7.4.3 Octapharma (Switzerland) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Octapharma (Switzerland) Coagulation Factor Concentrates Products Offered
7.4.5 Octapharma (Switzerland) Recent Development
7.5 Kedrion (Italy)
7.5.1 Kedrion (Italy) Corporation Information
7.5.2 Kedrion (Italy) Description and Business Overview
7.5.3 Kedrion (Italy) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Kedrion (Italy) Coagulation Factor Concentrates Products Offered
7.5.5 Kedrion (Italy) Recent Development
7.6 Bio Product Laboratory (UK)
7.6.1 Bio Product Laboratory (UK) Corporation Information
7.6.2 Bio Product Laboratory (UK) Description and Business Overview
7.6.3 Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Bio Product Laboratory (UK) Coagulation Factor Concentrates Products Offered
7.6.5 Bio Product Laboratory (UK) Recent Development
7.7 Sanquin (Netherlands)
7.7.1 Sanquin (Netherlands) Corporation Information
7.7.2 Sanquin (Netherlands) Description and Business Overview
7.7.3 Sanquin (Netherlands) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Sanquin (Netherlands) Coagulation Factor Concentrates Products Offered
7.7.5 Sanquin (Netherlands) Recent Development
7.8 LFB (France)
7.8.1 LFB (France) Corporation Information
7.8.2 LFB (France) Description and Business Overview
7.8.3 LFB (France) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
7.8.4 LFB (France) Coagulation Factor Concentrates Products Offered
7.8.5 LFB (France) Recent Development
7.9 Biotest (Germany)
7.9.1 Biotest (Germany) Corporation Information
7.9.2 Biotest (Germany) Description and Business Overview
7.9.3 Biotest (Germany) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Biotest (Germany) Coagulation Factor Concentrates Products Offered
7.9.5 Biotest (Germany) Recent Development
7.10 Japan Blood Products Organization, China Biologic Products (China)
7.10.1 Japan Blood Products Organization, China Biologic Products (China) Corporation Information
7.10.2 Japan Blood Products Organization, China Biologic Products (China) Description and Business Overview
7.10.3 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Products Offered
7.10.5 Japan Blood Products Organization, China Biologic Products (China) Recent Development
7.11 Green Cross Corporation (South Korea)
7.11.1 Green Cross Corporation (South Korea) Corporation Information
7.11.2 Green Cross Corporation (South Korea) Description and Business Overview
7.11.3 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Products Offered
7.11.5 Green Cross Corporation (South Korea) Recent Development
7.12 Shanghai RAAS Blood Products (China)
7.12.1 Shanghai RAAS Blood Products (China) Corporation Information
7.12.2 Shanghai RAAS Blood Products (China) Description and Business Overview
7.12.3 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Shanghai RAAS Blood Products (China) Products Offered
7.12.5 Shanghai RAAS Blood Products (China) Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Coagulation Factor Concentrates Industry Chain Analysis
8.2 Coagulation Factor Concentrates Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Coagulation Factor Concentrates Distributors
8.3 Coagulation Factor Concentrates Production Mode & Process
8.4 Coagulation Factor Concentrates Sales and Marketing
8.4.1 Coagulation Factor Concentrates Sales Channels
8.4.2 Coagulation Factor Concentrates Distributors
8.5 Coagulation Factor Concentrates Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Coagulation Factor Concentrates CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Coagulation Factor Concentrates Market Trends
Table 3. Coagulation Factor Concentrates Market Drivers
Table 4. Coagulation Factor Concentrates Market Challenges
Table 5. Coagulation Factor Concentrates Market Restraints
Table 6. Global Coagulation Factor Concentrates Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Coagulation Factor Concentrates Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Coagulation Factor Concentrates Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Coagulation Factor Concentrates Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Coagulation Factor Concentrates Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Coagulation Factor Concentrates Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Coagulation Factor Concentrates Revenue Share by Manufacturer, 2017-2022
Table 13. Global Coagulation Factor Concentrates Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Coagulation Factor Concentrates Sales Share by Manufacturer, 2017-2022
Table 15. Global Coagulation Factor Concentrates Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Coagulation Factor Concentrates Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Coagulation Factor Concentrates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation Factor Concentrates as of 2021)
Table 18. Top Players of Coagulation Factor Concentrates in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Coagulation Factor Concentrates Product Type
Table 20. Date of International Manufacturers Enter into Coagulation Factor Concentrates Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Coagulation Factor Concentrates Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Coagulation Factor Concentrates Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Coagulation Factor Concentrates Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Coagulation Factor Concentrates Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Coagulation Factor Concentrates Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Coagulation Factor Concentrates Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Coagulation Factor Concentrates Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Coagulation Factor Concentrates Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Coagulation Factor Concentrates Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Coagulation Factor Concentrates Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Coagulation Factor Concentrates Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Coagulation Factor Concentrates Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Coagulation Factor Concentrates Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Coagulation Factor Concentrates Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Coagulation Factor Concentrates Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Coagulation Factor Concentrates Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Coagulation Factor Concentrates Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Coagulation Factor Concentrates Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Coagulation Factor Concentrates Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Coagulation Factor Concentrates Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. CSL (Australia) Corporation Information
Table 43. CSL (Australia) Description and Business Overview
Table 44. CSL (Australia) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. CSL (Australia) Coagulation Factor Concentrates Product
Table 46. CSL (Australia) Recent Development
Table 47. Grifols (Spain) Corporation Information
Table 48. Grifols (Spain) Description and Business Overview
Table 49. Grifols (Spain) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Grifols (Spain) Product
Table 51. Grifols (Spain) Recent Development
Table 52. Shire (Ireland) Corporation Information
Table 53. Shire (Ireland) Description and Business Overview
Table 54. Shire (Ireland) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Shire (Ireland) Product
Table 56. Shire (Ireland) Recent Development
Table 57. Octapharma (Switzerland) Corporation Information
Table 58. Octapharma (Switzerland) Description and Business Overview
Table 59. Octapharma (Switzerland) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Octapharma (Switzerland) Product
Table 61. Octapharma (Switzerland) Recent Development
Table 62. Kedrion (Italy) Corporation Information
Table 63. Kedrion (Italy) Description and Business Overview
Table 64. Kedrion (Italy) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Kedrion (Italy) Product
Table 66. Kedrion (Italy) Recent Development
Table 67. Bio Product Laboratory (UK) Corporation Information
Table 68. Bio Product Laboratory (UK) Description and Business Overview
Table 69. Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Bio Product Laboratory (UK) Product
Table 71. Bio Product Laboratory (UK) Recent Development
Table 72. Sanquin (Netherlands) Corporation Information
Table 73. Sanquin (Netherlands) Description and Business Overview
Table 74. Sanquin (Netherlands) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Sanquin (Netherlands) Product
Table 76. Sanquin (Netherlands) Recent Development
Table 77. LFB (France) Corporation Information
Table 78. LFB (France) Description and Business Overview
Table 79. LFB (France) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. LFB (France) Product
Table 81. LFB (France) Recent Development
Table 82. Biotest (Germany) Corporation Information
Table 83. Biotest (Germany) Description and Business Overview
Table 84. Biotest (Germany) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Biotest (Germany) Product
Table 86. Biotest (Germany) Recent Development
Table 87. Japan Blood Products Organization, China Biologic Products (China) Corporation Information
Table 88. Japan Blood Products Organization, China Biologic Products (China) Description and Business Overview
Table 89. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Japan Blood Products Organization, China Biologic Products (China) Product
Table 91. Japan Blood Products Organization, China Biologic Products (China) Recent Development
Table 92. Green Cross Corporation (South Korea) Corporation Information
Table 93. Green Cross Corporation (South Korea) Description and Business Overview
Table 94. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Green Cross Corporation (South Korea) Product
Table 96. Green Cross Corporation (South Korea) Recent Development
Table 97. Shanghai RAAS Blood Products (China) Corporation Information
Table 98. Shanghai RAAS Blood Products (China) Description and Business Overview
Table 99. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. Shanghai RAAS Blood Products (China) Product
Table 101. Shanghai RAAS Blood Products (China) Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Coagulation Factor Concentrates Customers List
Table 105. Coagulation Factor Concentrates Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Coagulation Factor Concentrates Product Picture
Figure 2. Global Coagulation Factor Concentrates Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Coagulation Factor Concentrates Market Size 2017-2028 (US$ Million)
Figure 4. Global Coagulation Factor Concentrates Sales 2017-2028 (K Pcs)
Figure 5. United States Coagulation Factor Concentrates Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Coagulation Factor Concentrates Market Size 2017-2028 (US$ Million)
Figure 7. United States Coagulation Factor Concentrates Sales 2017-2028 (K Pcs)
Figure 8. United States Coagulation Factor Concentrates Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Coagulation Factor Concentrates Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Coagulation Factor Concentrates Report Years Considered
Figure 11. Product Picture of Factor VIII
Figure 12. Product Picture of Factor IX
Figure 13. Product Picture of Von Willebrand Factor
Figure 14. Product Picture of Prothrombin Complex Concentrates
Figure 15. Product Picture of Fibrinogen Concentrates
Figure 16. Product Picture of Factor XIII
Figure 17. Global Coagulation Factor Concentrates Market Share by Type in 2022 & 2028
Figure 18. Global Coagulation Factor Concentrates Sales in Value by Type (2017-2028) & (US$ Million)
Figure 19. Global Coagulation Factor Concentrates Sales Market Share in Value by Type (2017-2028)
Figure 20. Global Coagulation Factor Concentrates Sales by Type (2017-2028) & (K Pcs)
Figure 21. Global Coagulation Factor Concentrates Sales Market Share in Volume by Type (2017-2028)
Figure 22. Global Coagulation Factor Concentrates Price by Type (2017-2028) & (USD/Pcs)
Figure 23. United States Coagulation Factor Concentrates Market Share by Type in 2022 & 2028
Figure 24. United States Coagulation Factor Concentrates Sales in Value by Type (2017-2028) & (US$ Million)
Figure 25. United States Coagulation Factor Concentrates Sales Market Share in Value by Type (2017-2028)
Figure 26. United States Coagulation Factor Concentrates Sales by Type (2017-2028) & (K Pcs)
Figure 27. United States Coagulation Factor Concentrates Sales Market Share in Volume by Type (2017-2028)
Figure 28. United States Coagulation Factor Concentrates Price by Type (2017-2028) & (USD/Pcs)
Figure 29. Product Picture of Neurology
Figure 30. Product Picture of Immunology
Figure 31. Product Picture of Hematology
Figure 32. Product Picture of Critical Care
Figure 33. Product Picture of Pulmonology
Figure 34. Product Picture of Hemato-Oncology
Figure 35. Product Picture of Rheumatology
Figure 36. Product Picture of Others
Figure 37. Global Coagulation Factor Concentrates Market Share by Application in 2022 & 2028
Figure 38. Global Coagulation Factor Concentrates Sales in Value by Application (2017-2028) & (US$ Million)
Figure 39. Global Coagulation Factor Concentrates Sales Market Share in Value by Application (2017-2028)
Figure 40. Global Coagulation Factor Concentrates Sales by Application (2017-2028) & (K Pcs)
Figure 41. Global Coagulation Factor Concentrates Sales Market Share in Volume by Application (2017-2028)
Figure 42. Global Coagulation Factor Concentrates Price by Application (2017-2028) & (USD/Pcs)
Figure 43. United States Coagulation Factor Concentrates Market Share by Application in 2022 & 2028
Figure 44. United States Coagulation Factor Concentrates Sales in Value by Application (2017-2028) & (US$ Million)
Figure 45. United States Coagulation Factor Concentrates Sales Market Share in Value by Application (2017-2028)
Figure 46. United States Coagulation Factor Concentrates Sales by Application (2017-2028) & (K Pcs)
Figure 47. United States Coagulation Factor Concentrates Sales Market Share in Volume by Application (2017-2028)
Figure 48. United States Coagulation Factor Concentrates Price by Application (2017-2028) & (USD/Pcs)
Figure 49. North America Coagulation Factor Concentrates Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 50. North America Coagulation Factor Concentrates Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 51. U.S. Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Canada Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Europe Coagulation Factor Concentrates Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 54. Europe Coagulation Factor Concentrates Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. Germany Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. France Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. U.K. Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Italy Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Russia Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Asia-Pacific Coagulation Factor Concentrates Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 61. Asia-Pacific Coagulation Factor Concentrates Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 62. China Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Japan Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. South Korea Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. India Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Australia Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Taiwan Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Indonesia Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Thailand Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Malaysia Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Philippines Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Latin America Coagulation Factor Concentrates Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 73. Latin America Coagulation Factor Concentrates Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 74. Mexico Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Brazil Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Argentina Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. Middle East & Africa Coagulation Factor Concentrates Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 78. Middle East & Africa Coagulation Factor Concentrates Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 79. Turkey Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 80. Saudi Arabia Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 81. UAE Coagulation Factor Concentrates Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 82. Coagulation Factor Concentrates Value Chain
Figure 83. Coagulation Factor Concentrates Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed